Compare
DNA · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
DNA
Ginkgo Bioworks Holdings Inc
10.33
+0.10 (0.98%)
Valuation
| Index | RUT |
|---|---|
| Market Cap | $684.44M |
| Enterprise Value | 794.42M |
| Income | -275.54M |
| Sales | 100.74M |
| Book / share | 6.38 |
| Cash / share | 4.33 |
| Dividend Gr. 3/5Y | - - |
| Employees | 485 |
| IPO | Apr 19, 2021 |
Ratios
| Price / sales | 6.79 |
|---|---|
| Price / book | 1.62 |
| Price / cash | 2.38 |
| Value / sales | 7.89 |
| Quick Ratio | 4.72 |
| Current Ratio | 4.72 |
| Debt / equity | 1.01 |
| Long-term debt / equity | 1.01 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -4.63 |
|---|---|
| Earnings next year | -4.03 |
| Earnings next quarter | -1.04 |
| Earnings this year | 22.78% |
| Earnings growth, 5 years | 16.87% |
| Past earnings growth | 51.73% -7.49% |
| Past sales growth | -29.11% 17.29% |
| Earnings vs last year | 25.63% |
| Sales vs last year | -44.22% |
| Earnings vs last quarter | 55.86% |
| Sales vs last quarter | -28.65% |
| Earnings | Nov 05 AMC · 8 days ago |
| Surprise | 5.59% 28.89% |
Ownership
| Insiders own | 22.36% |
|---|---|
| Insider trades | -0.92% |
| Institutions own | 61.12% |
| Institution trades | 8.45% |
| Return on assets | -23.91% |
| Return on equity | -53.57% |
| Return on capital | -34.89% |
| Gross Margin | 40.40% |
| Operating margin | -242.27% |
| Profit Margin | -273.52% |
| 20-day average | -4.75% |
| 50-day average | 0.26% |
| 200-day average | 19.51% |
Technical
| Shares out | 53.62M |
|---|---|
| Shares floating | 49.11M |
| Short / float | 19.32% |
| Short ratio | 3.95 |
| Short interest | 9.49M |
| 52-week high | 18.22 -43.3% |
| 52-week low | 5.37 +92.4% |
| Volatility | 17.01% 12.98% |
| Average range | 1.37 |
| Strength index | 47.60 |
| Market sensitivity | 1.74 |
| Relative volume | 0.01 |
| Avg Volume | 2.40M |
| Volume | 1,611 |
Performance
| Perf Week | -8.50% |
|---|---|
| Perf Month | -12.16% |
| Perf Quarter | 49.28% |
| Perf Half Y | 33.98% |
| Perf YTD | 24.31% |
| Perf Year | 29.12% |
| Perf 3Y | -79.82% |
| Perf 5Y | -98.00% |
| Recommendation | 4.33 |
| Target Price | 8.00 |
| Prev Close | 10.23 |
| Price | 10.33 |
| Change % | 0.98% |
Compare
| DNA | |
|---|---|
| Price | 10.33 |
| Change | +0.10 (0.98%) |
Compare · Valuation
| DNA | |
|---|---|
| Index | RUT |
| Market Cap | $684.44M |
| Enterprise Value | 794.42M |
| Income | -275.54M |
| Sales | 100.74M |
| Book / share | 6.38 |
| Cash / share | 4.33 |
| Dividend Gr. 3/5Y | - - |
| Employees | 485 |
| IPO | Apr 19, 2021 |
Compare · Ratios
| DNA | |
|---|---|
| Price / sales | 6.79 |
| Price / book | 1.62 |
| Price / cash | 2.38 |
| Value / sales | 7.89 |
| Quick Ratio | 4.72 |
| Current Ratio | 4.72 |
| Debt / equity | 1.01 |
| Long-term debt / equity | 1.01 |
| Options and short | Yes / Yes |
Compare · Earnings
| DNA | |
|---|---|
| Earnings / share | -4.63 |
| Earnings next year | -4.03 |
| Earnings next quarter | -1.04 |
| Earnings this year | 22.78% |
| Earnings growth, 5 years | 16.87% |
| Past earnings growth | 51.73% -7.49% |
| Past sales growth | -29.11% 17.29% |
| Earnings vs last year | 25.63% |
| Sales vs last year | -44.22% |
| Earnings vs last quarter | 55.86% |
| Sales vs last quarter | -28.65% |
| Earnings | Nov 05 AMC · 8 days ago |
| Surprise | 5.59% 28.89% |
Compare · Ownership
| DNA | |
|---|---|
| Insiders own | 22.36% |
| Insider trades | -0.92% |
| Institutions own | 61.12% |
| Institution trades | 8.45% |
| Return on assets | -23.91% |
| Return on equity | -53.57% |
| Return on capital | -34.89% |
| Gross Margin | 40.40% |
| Operating margin | -242.27% |
| Profit Margin | -273.52% |
| 20-day average | -4.75% |
| 50-day average | 0.26% |
| 200-day average | 19.51% |
Compare · Technical
| DNA | |
|---|---|
| Shares out | 53.62M |
| Shares floating | 49.11M |
| Short / float | 19.32% |
| Short ratio | 3.95 |
| Short interest | 9.49M |
| 52-week high | 18.22 -43.3% |
| 52-week low | 5.37 +92.4% |
| Volatility | 17.01% 12.98% |
| Average range | 1.37 |
| Strength index | 47.60 |
| Market sensitivity | 1.74 |
| Relative volume | 0.01 |
| Avg Volume | 2.40M |
| Volume | 1,611 |
Compare · Performance
| DNA | |
|---|---|
| Perf Week | -8.50% |
| Perf Month | -12.16% |
| Perf Quarter | 49.28% |
| Perf Half Y | 33.98% |
| Perf YTD | 24.31% |
| Perf Year | 29.12% |
| Perf 3Y | -79.82% |
| Perf 5Y | -98.00% |
| Recommendation | 4.33 |
| Target Price | 8.00 |
| Prev Close | 10.23 |
| Price | 10.33 |
| Change % | 0.98% |